GLG Partners’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-276,408
Closed -$6.79M 376
2016
Q3
$6.79M Sell
276,408
-73,592
-21% -$1.9M 0.21% 138
2016
Q2
$7.05M Hold
350,000
0.21% 144
2016
Q1
$9.21M Buy
350,000
+172,655
+97% +$12.8M 0.26% 110
2015
Q4
$18M Buy
177,345
+158,204
+827% +$17.8M 0.57% 53
2015
Q3
$3.41M Buy
19,141
+14,141
+283% +$3.3M 0.09% 225
2015
Q2
$1.11M Sell
5,000
-31,000
-86% -$6.87M 0.03% 346
2015
Q1
$7.15M Sell
36,000
-18,093
-33% -$3.21M 0.24% 129
2014
Q4
$7.74M Sell
54,093
-14,062
-21% -$1.89M 0.23% 119
2014
Q3
$8.94M Buy
68,155
+16,785
+33% +$2M 0.2% 146
2014
Q2
$6.48M Buy
51,370
+36,027
+235% +$4.6M 0.15% 158
2014
Q1
$2.02M Buy
+15,343
New +$2.1M 0.04% 263

Other funds holding BHC

GLG Partners's BHC Position: Q4 2016 in Review

GLG Partners sold out of Bausch Health (BHC) in Q4 2016, closing a stake of 276,408 shares — an estimated $6.79M sold.

GLG Partners first reported a position in BHC in Q1 2014 and held it in 11 quarters. The position peaked at $18M in Q4 2015. 315 funds tracked by Wall St. Rank hold BHC as of Q4 2016.

  • GLG Partners reported no remaining Bausch Health position as of Q4 2016 after selling out during the quarter.
  • GLG Partners sold 276,408 Bausch Health shares in Q4 2016, an estimated $6.79M.
  • GLG Partners first reported a position in Bausch Health in Q1 2014 and held it in 11 quarters.
  • GLG Partners's Bausch Health position peaked at $18M in Q4 2015.
  • 315 funds tracked by Wall St. Rank held Bausch Health as of Q4 2016.

Based on GLG Partners's 13F filing for Q4 2016, filed 14 Feb 2017.